UNSPSC 51282912: Dequalinium

This classification denotes a quinolone antibiotic with the molecular formula C30H40N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7QC7V26B8, chemically known as quinolinium, 1,1-(1,10-decanediyl)bis(4-amino-2-methyl- but generally known as dequalinium, which bears US NIH Compound Identifier 2993. European Medicines Agency schedules Dequalinium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01590MIG.

UNSPSC 51282912 Dequalinium is a Commodity code that captures pharmaceutical active ingredients and specialty medications acquired by state and local health departments and county public health systems. The recent solicitation activity under this code reflects procurement of both narrow-spectrum antibiotics and opioid-antagonist medications — specifically doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone — purchased through both piggyback contracts against state cooperative purchasing vehicles and direct competitive bids. State health departments and county public health authorities are the primary issuing bodies, soliciting these products to support pharmacy stockpiling, emergency preparedness, and community health initiatives. The Illinois Department of Public Health and Seminole County, Florida represent the jurisdictions active in the recent record.

Activity under this code spans Illinois and Florida based on the most recent opportunities. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years (12-month initial term plus two one-year renewal options) for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing consortium under an Invitation for Bid process. Seminole County, Florida issued an IFB (No. IFB60459723LAS) with a response deadline of July 26, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the contract carries a two-year initial term with a one-year renewal option and includes potential FEMA funding with associated federal compliance requirements.